Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030298 · ClinicalTrials.gov registry record · Phase 1
Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
A Phase 1 study of Malignant Glioma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT05030298 is a Phase 1 study of Malignant Glioma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 91-participant average among 40 other Malignant Glioma trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05030298, a Phase 1 study of Malignant Glioma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
This phase I trial finds out the possible benefits and/or side effects of radiosurgery before surgery (preoperative) in treating patients with high grade glioma. Radiosurgery uses special equipment to position the patient and precisely give a single large dose of radiation to the tumor. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving pre-operative radiosurgery may improve the odds of brain tumor control and reduce treatment-related side effects.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
- DRUG Temozolomide
- RADIATION Radiosurgery
- PROCEDURE Stereotactic Biopsy
- PROCEDURE Tumor Treating Fields Therapy
Study Locations (2)
Arizona
- Mayo Clinic in Arizona - Phoenix
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2027-09-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05030298
The ClinicalTrials.gov registry entry for NCT05030298 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 40 other Malignant Glioma trials with a reported enrollment target (69% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Glioma appearing as the primary indexed condition, and to 5 interventions - of which Radiation Therapy is the first listed.
NCT05030298 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT05030298 about?
NCT05030298 is a clinical study titled "Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial". This phase I trial finds out the possible benefits and/or side effects of radiosurgery before surgery (preoperative) in treating patients with high grade glioma. Radiosurgery uses special equipment to position the patient and precisely give a single large dose of radiation to the tumor. This method ...
What is the current status of trial NCT05030298?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2023-05-23. Estimated completion is 2027-09-15.
What conditions does trial NCT05030298 study?
This clinical trial studies the following conditions: Malignant Glioma.
What interventions are being tested in trial NCT05030298?
The interventions under investigation include: Radiation Therapy (RADIATION), Temozolomide (DRUG), Radiosurgery (RADIATION), Stereotactic Biopsy (PROCEDURE), Tumor Treating Fields Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05030298?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05030298 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CARv3-TEAM-E T Cells in Glioblastoma
RECRUITING · Phase 1
-
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
RECRUITING · Phase 1
-
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RECRUITING · Phase 1
-
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
RECRUITING · Phase 1
-
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
ACTIVE NOT RECRUITING · Phase 1
-
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.